Medtronic Launches World’s First Real-Time Self-Adjusting Deep Brain Stimulation In Europe

BrainSense Adaptive DBS And BrainSense Electrode Identifier CE Marked

"Medtronic's device is the only DBS with adaptive capability," Amaza Reitmeier, vice president and general manager of Brain Modulation at Medtronic, told Medtech Insight. Two new BrainSense features work together to provide personalized brain stimulation for patients with Parkinson's disease.

Neurons
(Shutterstock)

Medtronic has announced CE marking for two new software features on its Percept Neurostimulator device, BrainSense Adaptive deep brain stimulation (aDBS) and BrainSense Electrode Identifier (EI), and reported first post-approval uses in European patients.

The two new features are wirelessly switched on in an implanted Percept device by a clinical programmer. Martijn Beudel, neurologist and associate professor at the Amsterdam University Medical Center, completed...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Neurology

More from Device Area